entertainment -WSS

entertainment

author：focus 2025-09-28 22:53:12 - browse：81

Illustration of three connected puzzle pieces, with a woman standing near the missing/empty puzzle piece space. -- first opinion coverage from STAT — Adobe

Women have always been underrepresented in medical research. A new study reveals that not much has changed, especially when it comes to tests of cardiovascular devices.

In a paper published in JAMA Internal Medicine on Monday, researchers found that the percentage of women represented in high-risk medical device trials did not increase from 2010 to 2020. Women generally made up just 33% of participants when the team reviewed 195 trials published from 2016 to 2022. The percentages varied between devices: Women made up 46% of participants in orthopedic trials, but 29% in cardiovascular studies.

The issue isn’t new. The government has made some strides in correcting earlier missteps, like the Food and Drug Administration telling researchers in 1977 to exclude women of reproductive potential from early clinical trials. But stakeholders think agencies like the FDA could do more to incentivize the enrollment of women.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： Hospitals consider fixing cancer drug shortages on their own

focus

entertainment

WSS

Researchers CRISPR chickens in bid to protect them from bird flu

A common UTI test for kids haunts adults as a traumatic 'nightmare'

Female surgeons have lower rates of long

FDA approves updated Covid vaccines

A common UTI test for kids haunts adults as a traumatic 'nightmare'

Regeneron agrees to White House price limits on anti

hotspot

entertainment

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

focus

FDA approval of Sarepta Duchenne genetic therapy gives me hope

European regulators consider appeal over Amylyx ALS drug

Medicare proposal to cover medical devices draws a mixed reaction

New Covid vaccine is recommended for everyone 6 months or older

Sports medicine is finally prioritizing gender equality

Researchers CRISPR chickens in bid to protect them from bird flu

Malaria cases in Florida and Texas: Here’s what you need to know

How should state employee insurance handle Wegovy?

What does generative AI mean for health care? We asked experts

Will the IRA bring competition to the biologics market?

hotspot

How medical schools plan to diversify without affirmative action

Life sciences deals on track to hit lowest point since 2017

Pig kidney works a record two months in donated body

Takeaways from AdvaMed, the largest medical devices conference

Generate Biomedicines machine learning biotech raises $273M

Eight reasons why you should get an updated Covid vaccine

focus

focus

entertainment

focus